市場調査レポート

商品コード

1705115

ヘルスケア分析試験サービスの世界市場：サービスタイプ別、サンプルタイプ別、エンドユーザー別、地域別、機会、予測、2018年～2032年

Healthcare Analytical Testing Services Market Assessment, By Service Type, By Sample Type, By End-user, By Region, Opportunities and Forecast, 2018-2032F

出版日: 2025年04月16日
発行: Market Xcel - Markets and Data
ページ情報: 英文 242 Pages
納期: 3～5営業日

カスタマイズ可能

価格

PDF & Excel Printable (Single User License)

USD 4,500 648,270円

レポートPDFを1名の方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能です。印刷は無制限で可能です。Excelのデータがライセンスに含まれています。

PDF & Excel Printable (Corporate License)

USD 5,700 821,142円

レポートPDFを企業の１カ国の拠点のすべての方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能ですが、企業内部での利用に限定されます。ご利用に際しては、あらかじめ出版社の許諾を得る必要があります。詳細はお問合せください。印刷は可能です。Excelのデータがライセンスに含まれています。

PDF & Excel Printable (Custom Research License)

USD 8,200 1,181,292円

レポートPDFを企業の１カ国の拠点のすべての方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能です。印刷は無制限で可能です。Excelのデータがライセンスに含まれています。アナリストアワー100時間が含まれており、レポートのカスタマイズなどにご利用いただけます。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=144.06円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界のヘルスケア分析試験サービスの市場規模は、予測期間の2025年～2032年のCAGRが10.17%に達し、2024年の83億7,000万米ドルから2032年には181億6,000万米ドルに成長すると予測されています。市場成長の背景には、臨床試験数の増加、バイオシミラー重視の高まり、製薬企業による製造アウトソーシングの増加があります。一方、遺伝子治療を含む革新的かつ新規の治療ソリューションに対する要求の高まりにより、市場の需要も増加しています。米国遺伝子細胞治療学会によると、2024年4月時点で32の遺伝子治療薬と28のRNA治療薬が承認されています。このように、分析試験サービスは、遺伝子治療製品の力価、純度、安定性の評価など、遺伝子治療製品の特性評価において重要な役割を担っているため、その必要性が高まっています。そのため、厳格な規制基準への適合が保証され、承認プロセスが加速されます。

ヘルスケア分析試験サービスは、医療・医薬品製品の安全性と有効性を保証するものであり、医薬品開発と製造プロセスにおいて不可欠な側面です。規制の厳格化、主要製薬企業による研究開発と製造活動のアウトソーシングの増加、ヘルスケアと医薬品に対する一貫した品質保証と管理に対する要求の高まりが、市場の成長をさらに促進しています。

当レポートでは、世界のヘルスケア分析試験サービス市場について調査し、市場の概要とともに、サービスタイプ別、サンプルタイプ別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

市場リーダートップ5の競合マトリックス
参入企業トップ5のSWOT分析
市場の主要企業トップ10の情勢
- Thermo Fisher Scientific, Inc.
- Charles River Laboratories International, Inc.
- Eurofins Scientific SE
- Labcorp Holdings Inc.
- ICON plc
- WuXi AppTec Co., Ltd.
- Medpace Holdings, Inc.
- Intertek Group plc
- SGS SA
- Toxikon, Inc.

第18章戦略的提言

第19章調査会社について・免責事項

図表

List of Tables

Table 1. Competition Matrix of Top 5 Market Leaders
Table 2. Mergers & Acquisitions/ Joint Ventures (If Applicable)
Table 3. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

Figure 1. Global Healthcare Analytical Testing Services Market, By Value, In USD Billion, 2018-2032F
Figure 2. Global Healthcare Analytical Testing Services Market Share (%), By Service Type, 2018-2032F
Figure 3. Global Healthcare Analytical Testing Services Market Share (%), By Sample Type, 2018-2032F
Figure 4. Global Healthcare Analytical Testing Services Market Share (%), By End-user, 2018-2032F
Figure 5. Global Healthcare Analytical Testing Services Market Share (%), By Region, 2018-2032F
Figure 6. North America Healthcare Analytical Testing Services Market, By Value, In USD Billion, 2018-2032F
Figure 7. North America Healthcare Analytical Testing Services Market Share (%), By Service Type, 2018-2032F
Figure 8. North America Healthcare Analytical Testing Services Market Share (%), By Sample Type, 2018-2032F
Figure 9. North America Healthcare Analytical Testing Services Market Share (%), By End-user, 2018-2032F
Figure 10. North America Healthcare Analytical Testing Services Market Share (%), By Country, 2018-2032F
Figure 11. United States Healthcare Analytical Testing Services Market, By Value, In USD Billion, 2018-2032F
Figure 12. United States Healthcare Analytical Testing Services Market Share (%), By Service Type, 2018-2032F
Figure 13. United States Healthcare Analytical Testing Services Market Share (%), By Sample Type, 2018-2032F
Figure 14. United States Healthcare Analytical Testing Services Market Share (%), By End-user, 2018-2032F
Figure 15. Canada Healthcare Analytical Testing Services Market, By Value, In USD Billion, 2018-2032F
Figure 16. Canada Healthcare Analytical Testing Services Market Share (%), By Service Type, 2018-2032F
Figure 17. Canada Healthcare Analytical Testing Services Market Share (%), By Sample Type, 2018-2032F
Figure 18. Canada Healthcare Analytical Testing Services Market Share (%), By End-user, 2018-2032F
Figure 19. Mexico Healthcare Analytical Testing Services Market, By Value, In USD Billion, 2018-2032F
Figure 20. Mexico Healthcare Analytical Testing Services Market Share (%), By Service Type, 2018-2032F
Figure 21. Mexico Healthcare Analytical Testing Services Market Share (%), By Sample Type, 2018-2032F
Figure 22. Mexico Healthcare Analytical Testing Services Market Share (%), By End-user, 2018-2032F
Figure 23. Europe Healthcare Analytical Testing Services Market, By Value, In USD Billion, 2018-2032F
Figure 24. Europe Healthcare Analytical Testing Services Market Share (%), By Service Type, 2018-2032F
Figure 25. Europe Healthcare Analytical Testing Services Market Share (%), By Sample Type, 2018-2032F
Figure 26. Europe Healthcare Analytical Testing Services Market Share (%), By End-user, 2018-2032F
Figure 27. Europe Healthcare Analytical Testing Services Market Share (%), By Country, 2018-2032F
Figure 28. Germany Healthcare Analytical Testing Services Market, By Value, In USD Billion, 2018-2032F
Figure 29. Germany Healthcare Analytical Testing Services Market Share (%), By Service Type, 2018-2032F
Figure 30. Germany Healthcare Analytical Testing Services Market Share (%), By Sample Type, 2018-2032F
Figure 31. Germany Healthcare Analytical Testing Services Market Share (%), By End-user, 2018-2032F
Figure 32. France Healthcare Analytical Testing Services Market, By Value, In USD Billion, 2018-2032F
Figure 33. France Healthcare Analytical Testing Services Market Share (%), By Service Type, 2018-2032F
Figure 34. France Healthcare Analytical Testing Services Market Share (%), By Sample Type, 2018-2032F
Figure 35. France Healthcare Analytical Testing Services Market Share (%), By End-user, 2018-2032F
Figure 36. Italy Healthcare Analytical Testing Services Market, By Value, In USD Billion, 2018-2032F
Figure 37. Italy Healthcare Analytical Testing Services Market Share (%), By Service Type, 2018-2032F
Figure 38. Italy Healthcare Analytical Testing Services Market Share (%), By Sample Type, 2018-2032F
Figure 39. Italy Healthcare Analytical Testing Services Market Share (%), By End-user, 2018-2032F
Figure 40. United Kingdom Healthcare Analytical Testing Services Market, By Value, In USD Billion, 2018-2032F
Figure 41. United Kingdom Healthcare Analytical Testing Services Market Share (%), By Service Type, 2018-2032F
Figure 42. United Kingdom Healthcare Analytical Testing Services Market Share (%), By Sample Type, 2018-2032F
Figure 43. United Kingdom Healthcare Analytical Testing Services Market Share (%), By End-user, 2018-2032F
Figure 44. Russia Healthcare Analytical Testing Services Market, By Value, In USD Billion, 2018-2032F
Figure 45. Russia Healthcare Analytical Testing Services Market Share (%), By Service Type, 2018-2032F
Figure 46. Russia Healthcare Analytical Testing Services Market Share (%), By Sample Type, 2018-2032F
Figure 47. Russia Healthcare Analytical Testing Services Market Share (%), By End-user, 2018-2032F
Figure 48. Netherlands Healthcare Analytical Testing Services Market, By Value, In USD Billion, 2018-2032F
Figure 49. Netherlands Healthcare Analytical Testing Services Market Share (%), By Service Type, 2018-2032F
Figure 50. Netherlands Healthcare Analytical Testing Services Market Share (%), By Sample Type, 2018-2032F
Figure 51. Netherlands Healthcare Analytical Testing Services Market Share (%), By End-user, 2018-2032F
Figure 52. Spain Healthcare Analytical Testing Services Market, By Value, In USD Billion, 2018-2032F
Figure 53. Spain Healthcare Analytical Testing Services Market Share (%), By Service Type, 2018-2032F
Figure 54. Spain Healthcare Analytical Testing Services Market Share (%), By Sample Type, 2018-2032F
Figure 55. Spain Healthcare Analytical Testing Services Market Share (%), By End-user, 2018-2032F
Figure 56. Turkey Healthcare Analytical Testing Services Market, By Value, In USD Billion, 2018-2032F
Figure 57. Turkey Healthcare Analytical Testing Services Market Share (%), By Service Type, 2018-2032F
Figure 58. Turkey Healthcare Analytical Testing Services Market Share (%), By Sample Type, 2018-2032F
Figure 59. Turkey Healthcare Analytical Testing Services Market Share (%), By End-user, 2018-2032F
Figure 60. Poland Healthcare Analytical Testing Services Market, By Value, In USD Billion, 2018-2032F
Figure 61. Poland Healthcare Analytical Testing Services Market Share (%), By Service Type, 2018-2032F
Figure 62. Poland Healthcare Analytical Testing Services Market Share (%), By Sample Type, 2018-2032F
Figure 63. Poland Healthcare Analytical Testing Services Market Share (%), By End-user, 2018-2032F
Figure 64. South America Healthcare Analytical Testing Services Market, By Value, In USD Billion, 2018-2032F
Figure 65. South America Healthcare Analytical Testing Services Market Share (%), By Service Type, 2018-2032F
Figure 66. South America Healthcare Analytical Testing Services Market Share (%), By Sample Type, 2018-2032F
Figure 67. South America Healthcare Analytical Testing Services Market Share (%), By End-user, 2018-2032F
Figure 68. South America Healthcare Analytical Testing Services Market Share (%), By Country, 2018-2032F
Figure 69. Brazil Healthcare Analytical Testing Services Market, By Value, In USD Billion, 2018-2032F
Figure 70. Brazil Healthcare Analytical Testing Services Market Share (%), By Service Type, 2018-2032F
Figure 71. Brazil Healthcare Analytical Testing Services Market Share (%), By Sample Type, 2018-2032F
Figure 72. Brazil Healthcare Analytical Testing Services Market Share (%), By End-user, 2018-2032F
Figure 73. Argentina Healthcare Analytical Testing Services Market, By Value, In USD Billion, 2018-2032F
Figure 74. Argentina Healthcare Analytical Testing Services Market Share (%), By Service Type, 2018-2032F
Figure 75. Argentina Healthcare Analytical Testing Services Market Share (%), By Sample Type, 2018-2032F
Figure 76. Argentina Healthcare Analytical Testing Services Market Share (%), By End-user, 2018-2032F
Figure 77. Asia-Pacific Healthcare Analytical Testing Services Market, By Value, In USD Billion, 2018-2032F
Figure 78. Asia-Pacific Healthcare Analytical Testing Services Market Share (%), By Service Type, 2018-2032F
Figure 79. Asia-Pacific Healthcare Analytical Testing Services Market Share (%), By Sample Type, 2018-2032F
Figure 80. Asia-Pacific Healthcare Analytical Testing Services Market Share (%), By End-user, 2018-2032F
Figure 81. Asia-Pacific Healthcare Analytical Testing Services Market Share (%), By Country, 2018-2032F
Figure 82. India Healthcare Analytical Testing Services Market, By Value, In USD Billion, 2018-2032F
Figure 83. India Healthcare Analytical Testing Services Market Share (%), By Service Type, 2018-2032F
Figure 84. India Healthcare Analytical Testing Services Market Share (%), By Sample Type, 2018-2032F
Figure 85. India Healthcare Analytical Testing Services Market Share (%), By End-user, 2018-2032F
Figure 86. China Healthcare Analytical Testing Services Market, By Value, In USD Billion, 2018-2032F
Figure 87. China Healthcare Analytical Testing Services Market Share (%), By Service Type, 2018-2032F
Figure 88. China Healthcare Analytical Testing Services Market Share (%), By Sample Type, 2018-2032F
Figure 89. China Healthcare Analytical Testing Services Market Share (%), By End-user, 2018-2032F
Figure 90. Japan Healthcare Analytical Testing Services Market, By Value, In USD Billion, 2018-2032F
Figure 91. Japan Healthcare Analytical Testing Services Market Share (%), By Service Type, 2018-2032F
Figure 92. Japan Healthcare Analytical Testing Services Market Share (%), By Sample Type, 2018-2032F
Figure 93. Japan Healthcare Analytical Testing Services Market Share (%), By End-user, 2018-2032F
Figure 94. Australia Healthcare Analytical Testing Services Market, By Value, In USD Billion, 2018-2032F
Figure 95. Australia Healthcare Analytical Testing Services Market Share (%), By Service Type, 2018-2032F
Figure 96. Australia Healthcare Analytical Testing Services Market Share (%), By Sample Type, 2018-2032F
Figure 97. Australia Healthcare Analytical Testing Services Market Share (%), By End-user, 2018-2032F
Figure 98. Vietnam Healthcare Analytical Testing Services Market, By Value, In USD Billion, 2018-2032F
Figure 99. Vietnam Healthcare Analytical Testing Services Market Share (%), By Service Type, 2018-2032F
Figure 100. Vietnam Healthcare Analytical Testing Services Market Share (%), By Sample Type, 2018-2032F
Figure 101. Vietnam Healthcare Analytical Testing Services Market Share (%), By End-user, 2018-2032F
Figure 102. South Korea Healthcare Analytical Testing Services Market, By Value, In USD Billion, 2018-2032F
Figure 103. South Korea Healthcare Analytical Testing Services Market Share (%), By Service Type, 2018-2032F
Figure 104. South Korea Healthcare Analytical Testing Services Market Share (%), By Sample Type, 2018-2032F
Figure 105. South Korea Healthcare Analytical Testing Services Market Share (%), By End-user, 2018-2032F
Figure 106. Indonesia Healthcare Analytical Testing Services Market, By Value, In USD Billion, 2018-2032F
Figure 107. Indonesia Healthcare Analytical Testing Services Market Share (%), By Service Type, 2018-2032F
Figure 108. Indonesia Healthcare Analytical Testing Services Market Share (%), By Sample Type, 2018-2032F
Figure 109. Indonesia Healthcare Analytical Testing Services Market Share (%), By End-user, 2018-2032F
Figure 110. Philippines Healthcare Analytical Testing Services Market, By Value, In USD Billion, 2018-2032F
Figure 111. Philippines Healthcare Analytical Testing Services Market Share (%), By Service Type, 2018-2032F
Figure 112. Philippines Healthcare Analytical Testing Services Market Share (%), By Sample Type, 2018-2032F
Figure 113. Philippines Healthcare Analytical Testing Services Market Share (%), By End-user, 2018-2032F
Figure 114. Middle East & Africa Healthcare Analytical Testing Services Market, By Value, In USD Billion, 2018-2032F
Figure 115. Middle East & Africa Healthcare Analytical Testing Services Market Share (%), By Service Type, 2018-2032F
Figure 116. Middle East & Africa Healthcare Analytical Testing Services Market Share (%), By Sample Type, 2018-2032F
Figure 117. Middle East & Africa Healthcare Analytical Testing Services Market Share (%), By End-user, 2018-2032F
Figure 118. Middle East & Africa Healthcare Analytical Testing Services Market Share (%), By Country, 2018-2032F
Figure 119. Saudi Arabia Healthcare Analytical Testing Services Market, By Value, In USD Billion, 2018-2032F
Figure 120. Saudi Arabia Healthcare Analytical Testing Services Market Share (%), By Service Type, 2018-2032F
Figure 121. Saudi Arabia Healthcare Analytical Testing Services Market Share (%), By Sample Type, 2018-2032F
Figure 122. Saudi Arabia Healthcare Analytical Testing Services Market Share (%), By End-user, 2018-2032F
Figure 123. UAE Healthcare Analytical Testing Services Market, By Value, In USD Billion, 2018-2032F
Figure 124. UAE Healthcare Analytical Testing Services Market Share (%), By Service Type, 2018-2032F
Figure 125. UAE Healthcare Analytical Testing Services Market Share (%), By Sample Type, 2018-2032F
Figure 126. UAE Healthcare Analytical Testing Services Market Share (%), By End-user, 2018-2032F
Figure 127. South Africa Healthcare Analytical Testing Services Market, By Value, In USD Billion, 2018-2032F
Figure 128. South Africa Healthcare Analytical Testing Services Market Share (%), By Service Type, 2018-2032F
Figure 129. South Africa Healthcare Analytical Testing Services Market Share (%), By Sample Type, 2018-2032F
Figure 130. South Africa Healthcare Analytical Testing Services Market Share (%), By End-user, 2018-2032F
Figure 131. By Service Type Map-Market Size (USD Billion) & Growth Rate (%), 2024
Figure 132. By Sample Type Map-Market Size (USD Billion) & Growth Rate (%), 2024
Figure 133. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2024
Figure 134. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2024

Product Code: MX12967

Global healthcare analytical testing services market is projected to witness a CAGR of 10.17% during the forecast period 2025-2032, growing from USD 8.37 billion in 2024 to USD 18.16 billion in 2032. The market's growth can be attributed to the increasing number of clinical trials, rising emphasis on biosimilars, and increasing manufacturing outsourcing by pharmaceutical companies. Meanwhile, the market's demand is also increasing due to the growing requirement for innovative and novel therapeutic solutions, including gene therapies. According to the American Society of Gene and Cell Therapy, 32 gene therapies and 28 RNA therapies have been approved as of April 2024. Thus, bolstering the requirement for analytical testing services as they play a crucial role in characterizing gene therapy products, including assessing their potency, purity, and stability. Thus, ensuring their compliance with stringent regulatory standards and accelerating the approval processes.

Healthcare analytical testing services ensure the safety and efficacy of medical and pharmaceutical products and are an essential aspect of the drug development and manufacturing processes. Rising regulatory stringency, increasing outsourcing of research and development and manufacturing activities by leading pharmaceutical companies, and the rising requirement for consistent quality assurance and control for healthcare and pharmaceutical products are further driving the growth of the market.

Increasing Pharmaceutical Outsourcing Boosts Market Demand

Pharmaceutical and biopharmaceutical companies are increasingly seeking contract research organizations (CROs) to comply with regulatory requirements and minimize internal costs. This increased reliance can also be attributed to the rapid expansion of pharmaceutical industries across the globe. According to India Brand Equity Foundation (IBEF), India has the highest number of United States Food and Drug Administration (US FDA) compliant pharmaceutical plants outside the United States and over 2000 World Health Organization- Good Manufacturing Practices (WHO-GMP) approved facilities.

Additionally, regulatory bodies such as the US FDA are tightening their quality assurance frameworks, necessitating greater testing accuracy and documentation, thus encouraging pharmaceutical companies to partner with external laboratories that provide advanced analytical testing services. The increasing requirement of complex biologics, biosimilars, and personalized therapies is creating additional demand for sophisticated testing protocols that ensure patient safety and product consistency. Thus, outsourcing provides a strategic and economic alternative to pharmaceutical companies that are working on remaining compliant and competitive in the rapidly evolving pharmaceutical industry.

Rising Requirement for Biologics and Biosimilars Supports Market Expansion

Biologics, including monoclonal antibodies, cell and gene therapies, and recombinant proteins, require rigorous analytical characterization as they are sensitive to environmental conditions due to their complex structure. Analytical testing of these products includes structural elucidation, potency assays, impurity profiling, and stability assessment. The rising prevalence of chronic diseases such as cancer, autoimmune disorders, and diabetes are also propelling the requirement for biologics. The American Cancer Society estimates that approximately 2,041,910 new cancer cases will be reported in the United States in 2025. This increase is thus creating the demand for constant quality assurance. Regulatory agencies are mandating extensive analytical data to provide approval to biologic and biosimilar products, resulting in the increased demand for specialized testing services that include chromatography, mass spectrometry, immunoassays, and cell-based assays.

Bioanalytical Testing Services Account for Significant Share of the Market

The growth of the segment can be attributed to its role in the evaluation of pharmacokinetics, pharmacodynamics, and bioequivalence studies during clinical trials. These testing services are essential for determining the absorption, distribution, metabolism, and excretion (ADME) profile of drugs, particularly for novel biosimilars, biologics, and specialty medications. Additionally, rising clinical trial volumes across phases I to IV, especially in oncology, and immunotherapy, are further increasing the demand for bioanalytical testing services. CROs and pharmaceutical companies are heavily investing in automation technologies and high-throughput platforms to meet this rising demand while ensuring regulatory compliance. Additionally, increasing acquisitions of various analytical service providers is also supporting the segment's growth. For instance, in December 2023, Sterling Accuris Wellness Private Limited acquired Vaibhav Analytical Services, an NABL-accredited laboratory that adheres to international standards and serves clients across India. The acquisition aligns with Sterling Accuris Diagnostics' commitment to advance healthcare through innovation and excellence in diagnostics and analytical testing services and allows the company to meet the growing demand for comprehensive testing solutions.

North America Holds Major Market Share

The market's growth in North America can be attributed to the strong presence of leading healthcare and pharmaceutical companies, rising requirement for high-end pharmaceuticals and medical devices to combat the growing threat of various diseases and disorders, and increasing need for regulated drug development processes to meet the safety standards. The growing number of ongoing clinical trials in the region are also positively influencing the market's growth. The demand for complete analytical testing services for biosimilars, vaccine development, and novel drug formulations has also increased in the region. Additionally, the leading service providers in the country are investing in expanding their analytical testing services. For instance, in March 2024, LGM Pharma LLC invested over USD 2 million in standalone analytical testing services (ATS) and expanded these services by 50% while adding suppository manufacturing capabilities to its contract development and manufacturing organization (CDMO) portfolio, at their facility in Texas, United States. The new suppository manufacturing capabilities address the growing demand for specialized drug delivery methods, particularly for geriatric, pediatric, and women's health needs. Such investments further supports the expansion of the market in North America.

Future Market Scenario (2025 - 2032F)

The market is expected to witness significant growth in the coming years as the demand for complex drug development, personalized medicine, and regulatory compliance increases. Increased investments in healthcare infrastructure by developing countries is expected to provide lucrative growth opportunities for the market. Meanwhile, Advances in automation, AI-integrated platforms, and high-throughput screening, among others, are aiding in improving the accuracy and efficiency of methodologies used in healthcare analytical testing.

The advent of cloud computing and big data analytics are expected to facilitate transformative changes in data management for healthcare analytical testing by allowing real-time analysis. Meanwhile, strategic mergers and acquisitions among contract research organizations (CROs), the entry of new players, and the expansion of service portfolios by various services providers are also expected to positively influence the market's expansion.

Key Players Landscape and Outlook

The key players of the market are focusing on strategic alliances and partnerships as they foster innovation, expand service portfolios, and enhance the ability of companies to meet regulatory requirements. By pooling resources and expertise, companies are also able to develop more precise and efficient analytical testing methods, which are crucial for ensuring the safety and efficacy of medical devices and pharmaceuticals.

For instance, in March 2024, Charles River Laboratories International, Inc. partnered with Wheeler Bio to combine their antibody discovery services with Wheeler's portable CMC platform to accelerate therapeutic discoveries. The strategic agreement offers a comprehensive solution that connects preclinical development, clinical manufacturing, and release testing processes. By incorporating CMC development early in the discovery phase, companies developing therapeutic solutions can leverage phase-appropriate manufacturing and analytics.

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. Global Healthcare Analytical Testing Services Market Outlook, 2018-2032F

4.1. Market Size Analysis & Forecast
- 4.1.1. By Value
4.2. Market Share Analysis & Forecast
- 4.2.1. By Service Type
  - 4.2.1.1. Bioanalytical Testing Services
    - 4.2.1.1.1. Pharmacokinetics (PK)
    - 4.2.1.1.2. Pharmacodynamics (PD)
    - 4.2.1.1.3. Bioavailability (BA)
    - 4.2.1.1.4. Bioequivalence (BE)
    - 4.2.1.1.5. Bioassays
    - 4.2.1.1.6. Others
  - 4.2.1.2. Physical Characterization
    - 4.2.1.2.1. Particle Size Analysis
    - 4.2.1.2.2. Thermal Analysis
    - 4.2.1.2.3. Surface Area Analysis
    - 4.2.1.2.4. Others
  - 4.2.1.3. Stability Testing
  - 4.2.1.4. Raw Material Testing
  - 4.2.1.5. Microbial Testing
    - 4.2.1.5.1. Bioburden Testing
    - 4.2.1.5.2. Sterility Testing
    - 4.2.1.5.3. Endotoxin Testing
    - 4.2.1.5.4. Microbial Identification
    - 4.2.1.5.5. Others
  - 4.2.1.6. Environmental Monitoring
  - 4.2.1.7. Method Development and Validation
  - 4.2.1.8. Other Services
- 4.2.2. By Sample Type
  - 4.2.2.1. Raw Material
  - 4.2.2.2. Finished Products
    - 4.2.2.2.1. Monoclonal Antibodies
    - 4.2.2.2.2. Vaccines
    - 4.2.2.2.3. Cell and Gene Therapy Products
- 4.2.3. By End-user
  - 4.2.3.1. Pharmaceutical and Biotechnology Companies
  - 4.2.3.2. Medical Device Manufacturers
  - 4.2.3.3. Contract Research Organizations (CROs)
  - 4.2.3.4. Academic and Research Institutes
  - 4.2.3.5. Others
- 4.2.4. By Region
  - 4.2.4.1. North America
  - 4.2.4.2. Europe
  - 4.2.4.3. Asia-Pacific
  - 4.2.4.4. South America
  - 4.2.4.5. Middle East and Africa
- 4.2.5. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2024)
4.3. Market Map Analysis, 2024
- 4.3.1. By Service Type
- 4.3.2. By Sample Type
- 4.3.3. By End-user
- 4.3.4. By Region

5. North America Healthcare Analytical Testing Services Market Outlook, 2018-2032F

5.1. Market Size Analysis & Forecast
- 5.1.1. By Value
5.2. Market Share Analysis & Forecast
- 5.2.1. By Service Type
  - 5.2.1.1. Bioanalytical Testing Services
    - 5.2.1.1.1. Pharmacokinetics (PK)
    - 5.2.1.1.2. Pharmacodynamics (PD)
    - 5.2.1.1.3. Bioavailability (BA)
    - 5.2.1.1.4. Bioequivalence (BE)
    - 5.2.1.1.5. Bioassays
    - 5.2.1.1.6. Others
  - 5.2.1.2. Physical Characterization
    - 5.2.1.2.1. Particle Size Analysis
    - 5.2.1.2.2. Thermal Analysis
    - 5.2.1.2.3. Surface Area Analysis
    - 5.2.1.2.4. Others
  - 5.2.1.3. Stability Testing
  - 5.2.1.4. Raw Material Testing
  - 5.2.1.5. Microbial Testing
    - 5.2.1.5.1. Bioburden Testing
    - 5.2.1.5.2. Sterility Testing
    - 5.2.1.5.3. Endotoxin Testing
    - 5.2.1.5.4. Microbial Identification
    - 5.2.1.5.5. Others
  - 5.2.1.6. Environmental Monitoring
  - 5.2.1.7. Method Development and Validation
  - 5.2.1.8. Other Services
- 5.2.2. By Sample Type
  - 5.2.2.1. Raw Material
  - 5.2.2.2. Finished Products
    - 5.2.2.2.1. Monoclonal Antibodies
    - 5.2.2.2.2. Vaccines
    - 5.2.2.2.3. Cell and Gene Therapy Products
- 5.2.3. By End-user
  - 5.2.3.1. Pharmaceutical and Biotechnology Companies
  - 5.2.3.2. Medical Device Manufacturers
  - 5.2.3.3. Contract Research Organizations (CROs)
  - 5.2.3.4. Academic and Research Institutes
  - 5.2.3.5. Others
- 5.2.4. By Country Share
  - 5.2.4.1. United States
  - 5.2.4.2. Canada
  - 5.2.4.3. Mexico
5.3. Country Market Assessment
- 5.3.1. United States Healthcare Analytical Testing Services Market Outlook, 2018-2032F*
  - 5.3.1.1. Market Size Analysis & Forecast
    - 5.3.1.1.1. By Value
  - 5.3.1.2. Market Share Analysis & Forecast
    - 5.3.1.2.1. By Service Type
      - 5.3.1.2.1.1. Bioanalytical Testing Services
      - 5.3.1.2.1.1.1. Pharmacokinetics (PK)
      - 5.3.1.2.1.1.2. Pharmacodynamics (PD)
      - 5.3.1.2.1.1.3. Bioavailability (BA)
      - 5.3.1.2.1.1.4. Bioequivalence (BE)
      - 5.3.1.2.1.1.5. Bioassays
      - 5.3.1.2.1.1.6. Others
      - 5.3.1.2.1.2. Physical Characterization
      - 5.3.1.2.1.2.1. Particle Size Analysis
      - 5.3.1.2.1.2.2. Thermal Analysis
      - 5.3.1.2.1.2.3. Surface Area Analysis
      - 5.3.1.2.1.2.4. Others
      - 5.3.1.2.1.3. Stability Testing
      - 5.3.1.2.1.4. Raw Material Testing
      - 5.3.1.2.1.5. Microbial Testing
      - 5.3.1.2.1.5.1. Bioburden Testing
      - 5.3.1.2.1.5.2. Sterility Testing
      - 5.3.1.2.1.5.3. Endotoxin Testing
      - 5.3.1.2.1.5.4. Microbial Identification
      - 5.3.1.2.1.5.5. Others
      - 5.3.1.2.1.6. Environmental Monitoring
      - 5.3.1.2.1.7. Method Development and Validation
      - 5.3.1.2.1.8. Other Services
    - 5.3.1.2.2. By Sample Type
      - 5.3.1.2.2.1. Raw Material
      - 5.3.1.2.2.2. Finished Products
      - 5.3.1.2.2.2.1. Monoclonal Antibodies
      - 5.3.1.2.2.2.2. Vaccines
      - 5.3.1.2.2.2.3. Cell and Gene Therapy Products
    - 5.3.1.2.3. By End-user
      - 5.3.1.2.3.1. Pharmaceutical and Biotechnology Companies
      - 5.3.1.2.3.2. Medical Device Manufacturers
      - 5.3.1.2.3.3. Contract Research Organizations (CROs)
      - 5.3.1.2.3.4. Academic and Research Institutes
      - 5.3.1.2.3.5. Others
- 5.3.2. Canada
- 5.3.3. Mexico

All segments will be provided for all regions and countries covered

6. Europe Healthcare Analytical Testing Services Market Outlook, 2018-2032F

6.1. Germany
6.2. France
6.3. Italy
6.4. United Kingdom
6.5. Russia
6.6. Netherlands
6.7. Spain
6.8. Turkey
6.9. Poland

7. Asia-Pacific Healthcare Analytical Testing Services Market Outlook, 2018-2032F

7.1. India
7.2. China
7.3. Japan
7.4. Australia
7.5. Vietnam
7.6. South Korea
7.7. Indonesia
7.8. Philippines

8. South America Healthcare Analytical Testing Services Market Outlook, 2018-2032F

8.1. Brazil
8.2. Argentina

9. Middle East and Africa Healthcare Analytical Testing Services Market Outlook, 2018-2032F

9.1. Saudi Arabia
9.2. UAE
9.3. South Africa

10. Demand Supply Analysis

11. Porter's Five Forces Analysis

12. PESTLE Analysis

13. Pricing Analysis

14. Market Dynamics

14.1. Market Drivers
14.2. Market Challenges

15. Market Trends and Developments

16. Case Studies

17. Competitive Landscape

17.1. Competition Matrix of Top 5 Market Leaders
17.2. SWOT Analysis for Top 5 Players
17.3. Key Players Landscape for Top 10 Market Players
- 17.3.1. Thermo Fisher Scientific, Inc.
  - 17.3.1.1. Company Details
  - 17.3.1.2. Key Management Personnel
  - 17.3.1.3. Products and Services
  - 17.3.1.4. Financials (As Reported)
  - 17.3.1.5. Key Market Focus and Geographical Presence
  - 17.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
- 17.3.2. Charles River Laboratories International, Inc.
- 17.3.3. Eurofins Scientific SE
- 17.3.4. Labcorp Holdings Inc.
- 17.3.5. ICON plc
- 17.3.6. WuXi AppTec Co., Ltd.
- 17.3.7. Medpace Holdings, Inc.
- 17.3.8. Intertek Group plc
- 17.3.9. SGS SA
- 17.3.10. Toxikon, Inc.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

ヘルスケア分析試験サービスの世界市場：サービスタイプ別、サンプルタイプ別、エンドユーザー別、地域別、機会、予測、2018年～2032年

Healthcare Analytical Testing Services Market Assessment, By Service Type, By Sample Type, By End-user, By Region, Opportunities and Forecast, 2018-2032F

目次

第1章 プロジェクトの範囲と定義

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 世界のヘルスケア分析試験サービス市場の見通し、2018年～2032年

第5章 北米のヘルスケア分析試験サービス市場の見通し、2018年～2032年

第6章 欧州のヘルスケア分析試験サービス市場の見通し、2018年～2032年

第7章 アジア太平洋のヘルスケア分析試験サービス市場の見通し、2018年～2032年

第8章 南米のヘルスケア分析試験サービス市場の見通し、2018年～2032年

第9章 中東・アフリカのヘルスケア分析試験サービス市場の見通し、2018年～2032年

第10章 需要供給分析

第11章 ポーターのファイブフォース分析

第12章 PESTLE分析

第13章 価格分析

第14章 市場力学

第15章 市場動向と発展

第16章 ケーススタディ

第17章 競合情勢

第18章 戦略的提言

第19章 調査会社について・免責事項

List of Tables

List of Figures

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. Global Healthcare Analytical Testing Services Market Outlook, 2018-2032F

5. North America Healthcare Analytical Testing Services Market Outlook, 2018-2032F

6. Europe Healthcare Analytical Testing Services Market Outlook, 2018-2032F

7. Asia-Pacific Healthcare Analytical Testing Services Market Outlook, 2018-2032F

8. South America Healthcare Analytical Testing Services Market Outlook, 2018-2032F

9. Middle East and Africa Healthcare Analytical Testing Services Market Outlook, 2018-2032F

10. Demand Supply Analysis

11. Porter's Five Forces Analysis

12. PESTLE Analysis

13. Pricing Analysis

14. Market Dynamics

15. Market Trends and Developments

16. Case Studies

17. Competitive Landscape

18. Strategic Recommendations

19. About Us and Disclaimer

第1章プロジェクトの範囲と定義

第2章調査手法

第3章エグゼクティブサマリー

第4章世界のヘルスケア分析試験サービス市場の見通し、2018年～2032年

第5章北米のヘルスケア分析試験サービス市場の見通し、2018年～2032年

第6章欧州のヘルスケア分析試験サービス市場の見通し、2018年～2032年

第7章アジア太平洋のヘルスケア分析試験サービス市場の見通し、2018年～2032年

第8章南米のヘルスケア分析試験サービス市場の見通し、2018年～2032年

第9章中東・アフリカのヘルスケア分析試験サービス市場の見通し、2018年～2032年

第10章需要供給分析

第11章ポーターのファイブフォース分析

第13章価格分析

第14章市場力学

第15章市場動向と発展

第16章ケーススタディ

第17章競合情勢

第18章戦略的提言

第19章調査会社について・免責事項